Merck plans $2.5 bln annual cost reductions, 8,500 job cuts
Oct 1 (Reuters) - U.S. drugmaker Merck & Co, taking a cue from other drugmakers that have slashed research spending to prop up earnings, on Tuesday said it plans to cut annual operating costs by about $2.5 billion by the end of 2015 and eliminate 8,500 jobs.
By slimming itself down, Merck said it would be able to bolster its pipeline of experimental drugs, many of which have failed to win regulatory approval or suffered other setbacks in the past few years.
- Air strike kills 15 civilians in Yemen by mistake: officials
- North Korea executes leader's powerful uncle in rare public purge |
- Student opens fire at Colorado high school, wounds two classmates
- Man arrested for suspected suicide plot to blow up Kansas airport |
- Hawaii official who released Obama birth certificate dies in plane crash